SANOFI VACCINES US INC.: $965M Department of Health and Human Services Contract Vehicle
Summary
This $965M CDC contract for the Vaccines for Children program is a routine annual renewal. The recipient, Sanofi Vaccines US Inc., is a private entity, so no direct public company exposure exists. The contract supports public health infrastructure but does not generate actionable market signals for retail investors.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No public company exposure – recipient is private, not a recognized public subsidiary.
- 2.Routine CDC contract for children's vaccines – not a new initiative or policy shift.
- 3.No legislation directly links to this award; unrelated bills have minimal sector impact.
Market Implications
This contract has no direct implications for publicly traded stocks. Investors seeking exposure to vaccine manufacturing should monitor other public companies (e.g., Merck, Pfizer) that participate in federal vaccine programs but this specific award is not attributable to them. The healthcare sector overall sees steady demand from government programs but this contract size relative to the sector is negligible.
Full Analysis
The Department of Health and Human Services, through the CDC, awarded a $965M indefinite delivery/indefinite quantity contract to Sanofi Vaccines US Inc. for the Vaccines for Children (VFC) program covering FY25 (April 2025 to March 2026). The VFC program provides free vaccines to eligible children and is a longstanding federal initiative. The recipient is a private entity (Sanofi Vaccines US Inc.), and per regulatory guidelines, this contract cannot be mapped to any publicly traded company, including its parent company Sanofi (SNY), because the award does not specify a clear public parent-subsidiary relationship that can be reliably attributed. There are no related bill signals that directly authorize or fund this specific contract; the listed bills address other policy areas. Consequently, no publicly traded companies, supply chain beneficiaries, or subcontractors can be identified with confidence. The contract is a routine operational renewal with negligible market-moving potential for public equities.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
GLAXOSMITHKLINE, LLC: $793M Department of Health and Human Services Contract Vehicle
SANOFI VACCINES US INC.: $580M Department of Health and Human Services Contract Vehicle
Strengthening the Vaccines for Children Program Act of 2026
GLAXOSMITHKLINE, LLC: $678M Department of Health and Human Services Contract Vehicle
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Delivering Gold Standard Childhood Vaccine Recommendations for Americans
This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.
Continuing to Protect the Meaning and Value of American Citizenship
This executive order directs federal agencies, including State, Justice, Homeland Security, and Social Security, to deny U.S. citizenship documentation to children born in the U.S. whose parents include alien enemies, foreign government employees, or those involved in commercial birth tourism or surrogacy, or who are born in territories without statutory citizenship. It implements a narrow interpretation of the Fourteenth Amendment following the Supreme Court's decision in Trump v. Barbara, effectively restricting birthright citizenship for specific categories of non-citizen parents.
Contract Details
Recipient
SANOFI VACCINES US INC.
Award Amount
$964,721,458
Awarding Agency
Department of Health and Human Services
Sub-Agency
Centers for Disease Control and Prevention
Contract Type
INDEFINITE DELIVERY / INDEFINITE QUANTITY
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →